Wilson Sonsini Goodrich & Rosati advised lead investor Enavate Sciences and new investor Longitude Capital in the financing. Global pharmaceutical company Zenas BioPharma announced a $118...
Zenas BioPharma’s $118 Million Series B Financing
Alpha-9 Theranostics’ C$11 Million Series A Financing
Torys LLP represented Longitude Capital on the transaction. On April 28, 2021, Alpha-9 Theranostics Inc. announced an C$11 million Series A financing to advance a portfolio...